Universal tumor screening for Lynch syndrome: Perceptions of Canadian pathologists and genetic counselors of barriers and facilitators.
Colorectal Neoplasms
Lynch syndrome
genetic counseling
pathologists
tumor screening
Journal
Cancer medicine
ISSN: 2045-7634
Titre abrégé: Cancer Med
Pays: United States
ID NLM: 101595310
Informations de publication
Date de publication:
07 2019
07 2019
Historique:
received:
30
01
2019
revised:
04
04
2019
accepted:
05
04
2019
pubmed:
19
5
2019
medline:
28
7
2020
entrez:
19
5
2019
Statut:
ppublish
Résumé
People at risk of developing hereditary cancers associated with Lynch Syndrome (LS) can be identified through universal screening of colorectal tumors. However, tumor screening practices are variable across Canada and few studies explore the perspectives of genetic counselors and pathologists about tumor screening. This study was conducted to better understand the barriers and facilitators of implementing universal tumor screening in health centers across Canada. An online survey about tumor screening programs was administered to genetic counselors and pathologists across Canada through communication channels of professional organizations. It was hosted on SurveyMonkey and accessible from October 2016 to March 2017. Barriers to tumor screening included a lack of sustainable resources, including funding and genetic counselors. Respondents strongly identified the need for a coordinated, interdisciplinary approach to program planning with the "right people at the table." Respondents currently with a screening program provided advice such as carefully designing the program structure, developing patient and family follow-up protocols, and ensuring adequate resources (funding, staff, training for providers) were available prior to program initiation. There is no national approach to universal tumor screening in Canada. However, future efforts can be informed by the experiences of those centers that have already created a universal tumor screening program for LS. These data suggest the need for an interdisciplinary approach, initial and sustained funding, and careful advanced planning of program structures and policies.
Sections du résumé
BACKGROUND
People at risk of developing hereditary cancers associated with Lynch Syndrome (LS) can be identified through universal screening of colorectal tumors. However, tumor screening practices are variable across Canada and few studies explore the perspectives of genetic counselors and pathologists about tumor screening. This study was conducted to better understand the barriers and facilitators of implementing universal tumor screening in health centers across Canada.
METHODS
An online survey about tumor screening programs was administered to genetic counselors and pathologists across Canada through communication channels of professional organizations. It was hosted on SurveyMonkey and accessible from October 2016 to March 2017.
RESULTS
Barriers to tumor screening included a lack of sustainable resources, including funding and genetic counselors. Respondents strongly identified the need for a coordinated, interdisciplinary approach to program planning with the "right people at the table." Respondents currently with a screening program provided advice such as carefully designing the program structure, developing patient and family follow-up protocols, and ensuring adequate resources (funding, staff, training for providers) were available prior to program initiation.
CONCLUSION
There is no national approach to universal tumor screening in Canada. However, future efforts can be informed by the experiences of those centers that have already created a universal tumor screening program for LS. These data suggest the need for an interdisciplinary approach, initial and sustained funding, and careful advanced planning of program structures and policies.
Identifiants
pubmed: 31102338
doi: 10.1002/cam4.2182
pmc: PMC6601578
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3614-3622Informations de copyright
© 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Références
Cancer Med. 2019 Jul;8(7):3614-3622
pubmed: 31102338
J Clin Oncol. 2012 Apr 1;30(10):1058-63
pubmed: 22355048
Genet Med. 2017 May;19(5):568-574
pubmed: 27711070
Dis Colon Rectum. 1991 May;34(5):424-5
pubmed: 2022152
Genet Med. 2012 Jan;14(1):152-62
pubmed: 22237445
J Natl Cancer Inst. 2004 Feb 18;96(4):261-8
pubmed: 14970275
Gastroenterology. 2014 Aug;147(2):502-26
pubmed: 25043945
Genet Med. 2010 Feb;12(2):93-104
pubmed: 20084010
Gastroenterology. 1999 Jun;116(6):1453-6
pubmed: 10348829
JAMA. 2011 Jun 8;305(22):2304-10
pubmed: 21642682
J Genet Couns. 2014 Feb;23(1):38-47
pubmed: 23674164
BMC Health Serv Res. 2018 Oct 30;18(1):824
pubmed: 30376847
Am J Surg Pathol. 2012 Apr;36(4):560-9
pubmed: 22301492
Genet Med. 2019 Jun;21(6):1381-1389
pubmed: 30349099
Genet Med. 2018 Oct;20(10):1131-1144
pubmed: 29300371
J Clin Pathol. 2015 Dec;68(12):1036-9
pubmed: 26201544
Ann Intern Med. 2011 Jul 19;155(2):69-79
pubmed: 21768580
J Clin Oncol. 2013 Jul 10;31(20):2554-62
pubmed: 23733757
Genet Med. 2009 Jan;11(1):42-65
pubmed: 19125127
Res Nurs Health. 2000 Aug;23(4):334-40
pubmed: 10940958
Genet Med. 2009 Jan;11(1):35-41
pubmed: 19125126
Genet Med. 2013 Dec;15(12):925-32
pubmed: 23598716
N Engl J Med. 2005 May 5;352(18):1851-60
pubmed: 15872200
Front Public Health. 2017 Sep 12;5:243
pubmed: 28955708
Gut. 2017 Mar;66(3):464-472
pubmed: 26657901
Cancer. 2015 Sep 15;121(18):3281-9
pubmed: 26036338
J Community Genet. 2019 Jul;10(3):335-344
pubmed: 30465127
Res Nurs Health. 2010 Feb;33(1):77-84
pubmed: 20014004
Genet Med. 2013 Dec;15(12):933-40
pubmed: 23639899
J Clin Oncol. 2008 Dec 10;26(35):5783-8
pubmed: 18809606
Genet Med. 2016 Feb;18(2):152-61
pubmed: 25880440
Fam Cancer. 2014 Mar;13(1):75-82
pubmed: 24002367
Am J Prev Med. 2010 Aug;39(2):184-8
pubmed: 20621267
Genet Med. 2014 Oct;16(10):773-82
pubmed: 24651603
J Natl Cancer Inst. 1997 Dec 3;89(23):1758-62
pubmed: 9392616
Clin Genet. 2017 May;91(5):672-682
pubmed: 27696385
J Genet Couns. 2015 Jun;24(3):421-7
pubmed: 25220566
Gastroenterology. 2018 Nov;155(5):1400-1409.e2
pubmed: 30063918
Clin Genet. 2009 Jul;76(1):1-18
pubmed: 19659756